Application 077273
- Type
- ANDA
- Sponsor
- ECR PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TUSSICAPS | CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX | CAPSULE, EXTENDED RELEASE;ORAL | EQ 8MG MALEATE;EQ 10MG BITARTRATE | No | Yes |
| 002 | TUSSICAPS | CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX | CAPSULE, EXTENDED RELEASE;ORAL | EQ 4MG MALEATE;EQ 5MG BITARTRATE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0187-0108 | TussiCaps | hydrocodone polistirex and chlorpheniramine polistirex | VALEANT PHARMACEUTICALS NORTH AMERICA LLC | ANDA | Current |
| 0187-0108 | TussiCaps | hydrocodone polistirex and chlorpheniramine polistirex | Bausch Health US LLC | ANDA | Current |
| 0187-0108 | TussiCaps | hydrocodone polistirex and chlorpheniramine polistirex | Bausch Health Americas Inc. | ANDA | Current |